FrancophonIA/ELRC3.0 huggingface dataset:
English: The vaccination may cause a slight rise in body temperature (less than 1°C) for a transient period (less than 48 hours after injection) without any consequence to the health or performance of the animal.
Danish: Vaccinationen kan forårsage en let temperaturforhøjelse (mindre end 1°C) i en forbigående periode (inden for 48 timer efter injektionen) uden nogen betydning for dyrets sundhed og ydelse.
English: a) the administration of the product to animals will interfere with the implementation of national programmes for the diagnosis, control or eradication of animal diseases, or will cause difficulties in certifying the absence of contamination in live animals or in foodstuffs or other products obtained from treated animals.
Danish: a) at behandling af dyr med veterinærlægemidlet griber forstyrrende ind i gennemførelsen af et nationalt program til diagnosticering, bekæmpelse eller udryddelse af sygdomme hos dyr eller gør det vanskeligt at bekræfte, at levende dyr eller levnedsmidler eller andre produkter hidrørende fra behandlede dyr ikke er kontamineret,
English: The excipients, including adjuvants, listed in section 6.1 of the SPC are either allowed substances for which table 1 of the annex to Commission Regulation (EU) No 37/2010 indicates that no MRLs are required or considered as not falling within the scope of Regulation (EC) No 470/2009 when used as in this veterinary medicinal product.
Danish: Hjælpestofferne (inklusive adjuvanser) som er anført i punkt 6.1 af SPC'et er enten tilladte hjælpestoffer, hvor tabel 1 i bilaget til Kommissionens forordning (EU) Nr. 37/2010 indikerer at MRL-værdier ikke er påkrævet eller som ikke anses for at være omfattet af Forordning (EF) nr. 470/2009, når de anvendes i et veterinærlægemiddel.
English: Revaccination: a booster injection should be administered at 6 month intervals.
Danish: Revaccination: En injektion bør administreres med 6 måneders intervaller.
English: Special precautions for use in animals: Vaccinate only healthy animals.
Danish: Særlige forholdsregler til brug hos dyr: Vacciner kun raske dyr.
English: Duration of immunity: 6 months.
Danish: Varighed af immunitet: 6 måneder.
English: Detailed information on this product is available on the website of the European Medicines Agency http://www.ema.europa.eu/
Danish: Yderligere information om dette lægemiddel er tilgængelig på Det Europæiske Lægemiddelagenturs hjemmeside http://www.ema.europa.eu/
English: Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu/
Danish: Yderligere information om dette veterinærlægemiddel er tilgængelig på Det Europæiske Lægemiddelagenturs hjemmeside http://www.ema.europa.eu/
English: These are rare and an appropriate symptomatic treatment should be administered.
Danish: Relevant symptomatisk behandling bør administreres.
English: Shake well prior to use.
Danish: Omrystes før brug.
English: The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals displaying adverse reactions during the course of one treatment) - common (more than 1 but less than 10 animals in 100 animals) - uncommon (more than 1 but less than 10 animals in 1,000 animals) - rare (more than 1 but less than 10 animals in 10,000 animals) - very rare (less than 1 animal in 10,000 animals, including isolated reports).
Danish: Hyppigheden af bivirkninger er defineret som: - Meget almindelige (flere end 1 ud af 10 dyr, der viser bivirkninger i løbet af en behandling) - Almindelige (flere end 1, men færre end 10 dyr ud af 100 dyr) - Ualmindelige (flere end 1, men færre end 10 dyr ud af 1.000 dyr) - Sjældne (flere end 1, men færre end 10 dyr ud af 10.000 dyr) - Meget sjældne (færre end 1 dyr ud af 10.000 dyr, herunder isolerede rapporter)
English: DATE ON WHICH THE PACKAGE LEAFLET WAS LAST APPROVED {DD/MM/YYYY}
Danish: DATO FOR SENESTE GODKENDELSE AF INDLÆGSSEDLEN {DD/MM/ÅÅÅÅ}
English: Allow the vaccine to reach a temperature of 15°C-25°C.
Danish: Vaccinen skal have en temperatur på 15°C - 25°C før ibrugtagning.
English: SPECIAL WARNING(S), IF NECESSARY Accidental injection is dangerous.
Danish: SÆRLIG(E) ADVARSEL/ADVARSLER, OM NØDVENDIGT Utilsigtet injektion er farlig.
English: Zero days
Danish: 0 dage.
English: No undesirable effects other than those mentioned in section 4.6 have been observed after the administration of an overdose.
Danish: Ingen bivirkninger, andre end de under punkt 4.6 “Bivirkninger” nævnte, er blevet observeret efter administration af en overdosis.
English: Pharmacotherapeutic group: Immunologicals, bovine rhinotracheitis virus (IBR) ATCvet code: QI02AA03
Danish: Farmakoterapeutisk gruppe: Immunologiske midler, bovin rhinotrakeitisvirus (IBR) ATCvet-kode: Q102AA03
English: If you are accidentally injected with this product, seek prompt medical advice even if only a very small amount is injected and take the package insert with you.
Danish: Hvis du ved et uheld injiceres med dette veterinærlægemiddel, skal du søge omgående lægehjælp, også selvom det kun drejer sig om en meget lille mængde, og tage indlægssedlen med dig.
English: Use sterile syringes and needles.
Danish: Anvend sterile sprøjter og kanyler.
English: The active substance being a principle of biological origin intended to produce active immunity is not within the scope of Regulation (EC) 470/2009.
Danish: Aktiv substans som principielt er af biologisk oprindelse hvis formål er at producere aktiv immunitet falder ikke indenfor anvendelsesområdet af Forordning (EF) nr. 470/2009 når det anvendes som i dette veterinære lægemiddel.
English: Laboratoire Porte des Alpes Rue de l'Aviation-69800 Saint Priest France
Danish: Laboratoire Porte des Alpes Rue de l'Aviation 69800 Saint Priest Frankrig
English: No undesirable effects other than those mentioned in the “Adverse reactions” section have been observed after the administration of an overdose.
Danish: Ingen bivirkninger, andre end de nævnt under punktet “Bivirkninger”, er blevet observeret efter administration af en overdosis.
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS 5 doses (10 ml)
Danish: MINDSTEKRAV TIL OPLYSNINGER PÅ SMÅ INDRE PAKNINGER 5 doser (10 ml)
English: EU/2/99/017/001 5 doses (10 ml) EU/2/99/017/004 10 x 5 doses (10 x 10 ml) EU/2/99/017/002 10 doses (20 ml) EU/2/99/017/005 10 x 10 doses (10 x 20 ml) EU/2/99/017/003 25 doses (50 ml) EU/2/99/017/006 10 x 25 doses (10 x 50 ml)
Danish: EU/2/99/017/001 5 doser (10 ml) EU/2/99/017/004 10 x 5 doser (10 x 10 ml) EU/2/99/017/002 10 doser (20 ml) EU/2/99/017/005 10 x 10 doser (10 x 20 ml) EU/2/99/017/003 25 doser (50 ml) EU/2/99/017/006 10 x 25 doser (10 x 50 ml)
English: The injection of the vaccine may cause a transient tissue reaction at the site of injection, which may persist for three weeks and rarely up to five weeks.
Danish: Injektion med vaccinen kan forårsage forbigående vævsreaktion på injektionsstedet, der kan persistere i tre uger, i sjældne tilfælde op til 5 uger.
English: 25 doses (50 ml)
Danish: 25 doser (50 ml)
English: Bovalto Ibraxion can therefore be used as a marker vaccine in association with an appropriate diagnostic test.
Danish: Bovalto Ibraxion kan anvendes som en markør vaccine i forbindelse med en passende diagnostisk testmetode.
English: BATCH NUMBER
Danish: BATCHNUMMER Lot{nummer}
English: MANUFACTURER'S BATCH NUMBER Lot
Danish: FREMSTILLERENS BATCHNUMMER Lot {nummer}
English: For use in animals from the age of 2 weeks in the absence of maternally derived antibodies against IBR virus or from the age of 3 months in the presence of maternally derived antibodies.
Danish: Kan anvendes til dyr fra 2 ugers alderen, ved fravær af maternelle antistoffer overfor IBR-virus eller fra 3 måneders alderen ved tilstedeværelse af maternelle antistoffer
English: Polyoxyethylene oleate Polyoxyethylene oleic alcohol Potassium chloride, Sodium chloride, Potassium dihydrogen phosphate, Disodium phosphate dihydrate, Magnesium chloride, Calcium chloride
Danish: Paraffinolie, tynd Benzylalkohol Triethanolamin Polyoxyethylenoleat Polyoxyethylenoleylalkohol Kaliumchlorid Natriumchlorid Kaliumdihydrogenphosphat Dinatriumphosphatdihydrat Magnesiumchlorid Calciumchlorid
English: Administer one dose (2 ml) by subcutaneous injection in the neck (at the front of the shoulder) according to the following regimen:
Danish: 1 dosis (2 ml) injiceres subkutant i halsmuskulaturen i henhold til følgende program:
English: The presence of maternally derived antibodies against infectious bovine rhinotracheitis virus may interfere with the vaccination and requires an appropriate vaccination regimen.
Danish: Tilstedeværelse af maternelle antistoffer over for infektiøs bovin rhinotracheitis virus kan interferere med vaccinationen og kræver nøjagtig udført vaccinationsprogram.
English: The gE gene deletion allows differentiation between animals vaccinated with gE-negative vaccines (anti gE antibody negative, IBR vironeutralising antibody positive) and naturally infected animals (positive to both IBR vironeutralising antibody and anti gE antibody).
Danish: Fjernelsen af gE-genet muliggør differentiering mellem dyr vaccineret med gE-negative vacciner (anti gE antistof negative, IBR vironeutraliserende antistof positive) og naturligt inficerede dyr (positive over for både IBR vironeutraliserende antistof og anti gE antistof).
English: Pregnancy and lactation: Bovalto Ibraxion can be used during pregnancy and lactation.
Danish: Drægtighed og laktation: Bovalto Ibraxion kan anvendes under drægtighed og laktation.
English: Two injections 21 days apart.
Danish: Basisvaccination: to injektioner med et interval på 21 dage.
English: QUANTITY OF THE ACTIVE SUBSTANCE(S) For 1 dose of 2 ml: gE deleted inactivated IBR virus, at least ................................................ 0.75 VN.U
Danish: MÆNGDEN AF AKTIVT STOF (AKTIVE STOFFER) Per dosis à 2 ml: gE-deleted, inaktiveret IBR-virus, min. ....................................................... 0,75 VN.U
English: Manufacturer responsible for batch release MERIAL
Danish: Fremstiller ansvarlig for batchfrigivelse Merial
English: MERIAL,Laboratoire Lyon Gerland 254, Avenue Marcel Mérieux-69007 Lyon FRANCE
Danish: Laboratoire Lyon Gerland 254, Avenue Marcel Mérieux 69007 Lyon
English: A hypersensitivity reaction may occur.
Danish: Vaccinationen kan undtagelsesvis give anledning til overfølsomhedsreaktion.
English: Bovalto Ibraxion can be used during pregnancy and lactation.
Danish: Bovalto Ibraxion can anvendes under drægtighed og laktation.
English: A. MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURRER RESPONSIBLE FOR BATCH RELEASE
Danish: A. FREMSTILLER AF DET BIOLOGISK AKTIVE STOF FREMSTILLER ANSVARLIG FOR BATCHFRIGIVELSE
English: 5 doses (10 ml) 10 x 5 doses (10 x 10 ml) 10 doses (20 ml) 10 x 10 doses (10 x 20 ml) 25 doses (50 ml) 10 x 25 doses (10 x 50 ml)
Danish: 5 doser (10 ml) 10 x 5 doser (10 x 10 ml) 10 doser (20 ml) 10 x 10 doser (10 x 20 ml) 25 doser (50 ml) 10 x 25 doser (10 x 50 ml)
English: WITHDRAWAL PERIOD Withdrawal period: zero days.
Danish: TILBAGEHOLDELSESTID Tilbageholdelsestid: Nul dage.
English: Special precautions to be taken by the person administering the veterinary medicinal product to animals:
Danish: Særlige forholdsregler der skal træffes af personer, der administrerer lægemidlet til dyr: Til brugeren:
English: QUALITATIVE AND QUANTITATIVE COMPOSITION
Danish: KVALITATIV OG KVANTITATIV SAMMENSÆTNING Aktivt stof :
English: Onset of immunity: 14 days
Danish: Indtræden af immunitet: 14 dage.
English: The manufacture, import, possession, sale, supply and/or use of Bovalto Ibraxion may be prohibited in a Member State on the whole or part of its territory pursuant to national legislation.
Danish: Fremstilling, indførsel, besiddelse, salg, levering og/eller anvendelse af Bovalto Ibraxion er eller kan være forbudt i en medlemsstat på hele eller en del af dens område i henhold til national lovgivning.
English: Type I glass bottles with a Nitrile elastomer closure and sealed with an aluminium cap Cardboard box with 1 or 10 bottles of 5 doses (1 x 10 ml or 10 x 10 ml) Cardboard box with 1 or 10 bottles of 10 doses (1 x 20 ml or 10 x 20 ml) Cardboard box with 1 or 10 bottles of 25 doses (1 x 50 ml or 10 x 50 ml)
Danish: Æske med 1 eller 10 flasker á 5 doser (1 x 10 ml eller 10 x 10 ml) Æske med 1 eller 10 flasker á 10 doser (1 x 20 ml eller 10 x 20 ml) Æske med 1 eller 10 flasker á 25 doser (1 x 50 ml eller 10 x 50 ml)
English: WITHDRAWAL PERIOD Withdrawal period: Zero days
Danish: TILBAGEHOLDELSESTID Tilbageholdelsestid: 0 dage
English: Any person intending to manufacture, import, possess, sell, supply and/or use Bovalto Ibraxion must consult the relevant Member State's competent authority on the current vaccination policies prior to the manufacture, import, possession,sale, supply and/or use.
Danish: Enhver, som har til hensigt at fremstille, indføre, besidde, sælge, levere og/eller anvende Bovalto Ibraxion, skal rådføre sig med den relevante medlemsstats kompetente myndighed vedrørende gældende vaccinationspolitik forinden fremstilling, indførsel, besiddelse, salg, levering og/eller anvendelse finder sted.
English: Shelf life of the veterinary medicinal product as packaged for sale: 18 months Shelf life after first opening the immediate packaging: 6 hours
Danish: Opbevaringstid for veterinærlægemidlet i salgspakning: 18 måneder.
English: Active immunisation of cattle to reduce the clinical signs of infectious bovine rhinotracheitis (IBR) and field virus excretion.
Danish: Aktiv immunisering af kvæg resulterende i en nedsættelse af kliniske symptomer på infektiøs bovin rhinotracheitis (IBR) og udskillelse af markvirus.
English: PHARMACEUTICAL FORM Emulsion for injection
Danish: LÆGEMIDDELFORM Injektionvæske, emulsion.
English: PACKAGE LEAFLET FOR Bovalto Ibraxion emulsion for injection
Danish: INDLÆGSSEDDEL FOR: Bovalto Ibraxion emulsion til injektion
English: The import, possession, sale, supply and/or use of this veterinary medicinal product may be prohibited in a Member State on the whole or part of its territory, see package leaflet for further information.
Danish: Indførsel, besiddelse, salg, levering og/eller anvendelse af dette veterinærlægemiddel er eller kan være forbudt i en medlemsstat på dele af eller hele dens område.
English: 4.2 Indications for use, specifying the target species Active immunisation of cattle to reduce the clinical signs of infectious bovine rhinotracheitis (IBR) and field virus excretion.
Danish: 4.2 Terapeutiske indikationer med angivelse af dyrearter, som lægemidlet er beregnet til Aktiv immunisering af kvæg resulterende i en nedsættelse af kliniske symptomer på infektiøs bovin rhinotracheitis (IBR) og udskillelse af markvirus.
English: 29 avenue Tony Garnier 69007 LYON France
Danish: 29 avenue Tony Garnier 69007 Lyon Frankrig
English: CONTENTS BY WEIGHT, BY VOLUME OR BY NUMBER OF DOSES 5 doses (10 ml)
Danish: PAKNINGSSTØRRELSE ANGIVET SOM VÆGT, VOLUMEN ELLER ANTAL DOSER
English: Shelf life after first opening the container: 6 hours Do not use this veterinary medicinal product after the expiry date which is stated on the label after EXP.
Danish: Må ikke anvendes efter den udløbsdato, som er angivet på etiketten efter EXP.
English: Marketing authorisation holder MERIAL
Danish: Indehaver af markedsføringstilladelse MERIAL
English: NAME OF THE VETERINARY MEDICINAL PRODUCT Bovalto Ibraxion emulsion for injection
Danish: VETERINÆRLÆGEMIDLETS NAVN Bovalto Ibraxion injektionsvæske, emulsion.
English: Each dose (2 ml) contains: gE deleted inactivated IBR virus, at least ............................................................................. 0.75 VN.U* adjuvant: light paraffin oil ........................................................................................... 449.6 to 488.2 mg * VN.U: Vironeutralising antibody titre after vaccine injection in guinea pigs.
Danish: En dosis på 2 ml indeholder: gE-deleted, inaktiveret IBR-virus, min. ................................................................................. 0,75 VN.U* adjuvans: tynd paraffin olie ............................................................................................ 449,6 - 488,2 mg * VN.U: vironeutraliserende antistoftiter efter vaccination af marsvin
English: Type I glass bottles with a Nitrile elastomer closure and sealed with an aluminium cap Cardboard box with 1 or 10 bottles of 5 doses Cardboard box with 1 or 10 bottles of 10 doses Cardboard box with 1 or 10 bottles of 25 doses
Danish: Æske med 1 eller 10 flasker á 25 doser.
English: Bovalto Ibraxion is a gene specific deleted (gE), inactivated and adjuvanted (o/w emulsion) vaccine which acts by the active immunisation of cattle characterised by the production of Infectious Bovine Rhinotracheitis (IBR) vironeutralising antibodies.
Danish: Vaccinen virker ved en aktiv immunisering af kvæg ved dannelse af Infektiøs Bovin Rhinotracheitis (IBR) vironeutraliserende antistoffer.
English: EXPIRY DATE EXP {month/year} Once broached use by: 6 hours
Danish: 10. UDLØBSDATO EXP {måneder/år}
English: STATEMENT OF ACTIVE AND OTHER SUBSTANCES For 1 dose of 2 ml: .gE deleted inactivated IBR virus, at least ............................................................................ 0.75 VN.U* .light paraffin oil ......................................................................................................... 449.6 to 488.2 mg * VN.U: Vironeutralising antibody titre after vaccine injection in guinea pigs
Danish: • tynd paraffinolie ........................................................................................................ 449,6 - 488,2 mg * VN.U: vironeutraliserende antistoftiter efter vaccination af marsvin
English: Active substance
Danish: BIVIRKNINGER
English: TARGET SPECIES
Danish: DYREARTER Kvæg.
English: WITHDRAWAL PERIOD Zero days
Danish: 10. TILBAGEHOLDELSESTID 0 dage.
English: Retacrit is used in the following situations:
Danish: Retacrit anvendes i følgende situationer:
English: After that, the two groups switched to receiving the other medicine for a further 12 weeks.
Danish: Derefter skiftede begge grupper over til det andet lægemiddel i yderligere 12 uger.
English: The European Commission granted a marketing authorisation valid throughout the EU for Retacrit on 18 December 2007.
Danish: Europa-Kommissionen udstedte en markedsføringstilladelse med gyldighed i hele Den Europæiske Union for Retacrit den 18. december 2007.
English: This document is a summary of the European Public Assessment Report (EPAR) for Retacrit.
Danish: Dette dokument er et sammendrag af den europæiske offentlige vurderingsrapport (EPAR) for Retacrit.
English: The full EPAR for Retacrit can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Danish: Den fuldstændige EPAR for Retacrit findes på agenturets websted: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
English: The lowest dose that provides adequate control of symptoms should be used.
Danish: Den laveste dosis, som regulerer symptomerne tilstrækkeligt, skal anvendes.
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Retacrit.
Danish: Det forklarer, hvordan Udvalget for Humanmedicinske Lægemidler (CHMP) vurderede lægemidlet og nåede frem til sin udtalelse til fordel for udstedelse af en markedsføringstilladelse og til sine anbefalinger om anvendelsesbetingelserne for Retacrit.
English: Retacrit is a ‘biosimilar' medicine.
Danish: Retacrit er et ‘biosimilært' lægemiddel.
English: It is produced by a method known as ‘recombinant DNA technology': it is made by a cell that has received a gene (DNA), which makes it able to produce epoetin zeta.
Danish: Det fremstilles ved hjælp af en metode kaldet ‘rekombinant dna-teknologi': Det fremstilles af en celle, som har modtaget et gen (DNA), der sætter den i stand til at danne epoetin zeta.
English: The iron levels of all patients should be checked before treatment to make sure that they are not too low, and iron supplements should be used throughout treatment.
Danish: Jernindholdet skal kontrolleres hos alle patienter inden behandling for at sikre, at det ikke er for lavt, og der bør gives jerntilskud under hele behandlingen.
English: This means that Retacrit is similar to a biological medicine (the ‘reference medicine') that is already authorised in the European Union (EU), and contains a similar active substance to the reference medicine.
Danish: Det betyder, at Retacrit svarer til et biologisk lægemiddel (‘referencelægemidlet'), som allerede er godkendt i Den Europæiske Union (EU), og som indeholder det samme aktive stof.
English: In both studies, the dose of epoetin received was similar with both medicines.
Danish: I begge undersøgelser var den anvendte dosis epoetin den samme for begge lægemidler.
English: It is available in prefilled syringes containing between 1,000 and 40,000 international units (IU) of the active substance, epoetin zeta.
Danish: Det fås i fyldte injektionssprøjter, som indeholder mellem 1 000 og 40 000 internationale enheder (IE) af det aktive stof epoetin zeta.
English: The Committee recommended that Retacrit be given marketing authorisation.
Danish: Udvalget anbefalede udstedelse af markedsføringstilladelse for Retacrit.
English: Retacrit should not be used in people who may be hypersensitive (allergic) to epoetin zeta or any of the other ingredients.
Danish: Retacrit må ikke gives til personer, der kan være overfølsomme (allergiske) over for epoetin zeta eller andre af indholdsstofferne.
English: In these cases, erythropoietin is used to replace the missing hormone or to increase red blood cell counts.
Danish: I disse tilfælde anvendes erytropoietin til at erstatte det manglende hormon eller til at øge antallet af røde blodlegemer.
English: For patients with chronic renal failure or receiving chemotherapy, haemoglobin levels should remain within the recommended range (between 10 and 12 grams per decilitre in adults and between 9.5 and 11 g/dl in children).
Danish: Til patienter med kronisk nyreinsufficiens eller patienter i kemoterapi skal hæmoglobinniveauerne holdes inden for det anbefalede interval (mellem 10 og 12 gram pr. deciliter hos voksne og mellem 9,5 og 11 g/dl hos børn).
English: Retacrit was also effective when it was injected under the skin.
Danish: Retacrit var også effektivt, når det blev givet ved indsprøjtning under huden.
English: The study in patients receiving chemotherapy showed that Retacrit brought about similar improvements in haemoglobin levels as those reported in the scientific literature for other epoetins.
Danish: Undersøgelsen hos patienter i kemoterapi viste, at Retacrit gav de samme forbedringer i hæmoglobinniveauet som dem, der er beskrevet i den videnskabelige litteratur for andre epoetiner.
English: Treatment with Retacrit must be started under the supervision of doctors who have experience in the management of patients with the conditions that the medicine is used for.
Danish: Behandling med Retacrit skal indledes under tilsyn af en læge, som har erfaring i behandling af patienter med de sygdomme, lægemidlet er beregnet til.
English: Retacrit was also as effective as the reference medicine in patients with kidney problems.
Danish: Retacrit var desuden lige så effektivt som referencelægemidlet hos patienter med nyreproblemer.
English: For more information about treatment with Retacrit, read the Package Leaflet (also part of the EPAR).
Danish: De nærmere oplysninger om behandling med Retacrit fremgår af indlægssedlen (også en del af denne EPAR).
English: The dose, the frequency of injection and how long Retacrit is used for depend on why it is being used, and are adjusted according to the patient's response.
Danish: Dosisstørrelsen, injektionshyppigheden og Retacrit-behandlingens varighed afhænger af, hvilken tilstand der behandles, og skal tilpasses patientens respons.